BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18411288)

  • 21. [Immunopotency of the recombinant urease B subunit vaccine of Helicobacter pylori after intranasal administration to mice].
    Gao ZG; Zou QM; Guo G; Guo TS; Zou QM; Zeng WK; Xie QH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):68-70. PubMed ID: 15132912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model.
    Gonzalez D; Tzianabos AO; Genco CA; Gibson FC
    Infect Immun; 2003 Apr; 71(4):2283-7. PubMed ID: 12654858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bactericidal activity of a monoclonal antibody against a recombinant 40-kDa outer membrane protein of Porphyromonas gingivalis.
    Katoh M; Saito S; Takiguchi H; Abiko Y
    J Periodontol; 2000 Mar; 71(3):368-75. PubMed ID: 10776923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with recombinant RgpA peptide protects against Porphyromonas gingivalis-induced bone loss.
    Wilensky A; Potempa J; Houri-Haddad Y; Shapira L
    J Periodontal Res; 2017 Apr; 52(2):285-291. PubMed ID: 27282938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opsonophagocytic effect of antibody against recombinant conserved 40-kDa outer membrane protein of Porphyromonas gingivalis.
    Saito S; Hayakawa M; Takiguchi H; Abiko Y
    J Periodontol; 1999 Jun; 70(6):610-7. PubMed ID: 10397516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local and systemic immune responses induced by a recombinant chimeric protein containing Mycoplasma hyopneumoniae antigens fused to the B subunit of Escherichia coli heat-labile enterotoxin LTB.
    Marchioro SB; Fisch A; Gomes CK; Jorge S; Galli V; Haesebrouck F; Maes D; Dellagostin O; Conceição FR
    Vet Microbiol; 2014 Sep; 173(1-2):166-71. PubMed ID: 25091529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of the quillaja saponin semi-synthetic analog GPI-0100 in potentiating mucosal and systemic responses to recombinant HagB from Porphyromonas gingivalis.
    Zhang P; Yang QB; Marciani DJ; Martin M; Clements JD; Michalek SM; Katz J
    Vaccine; 2003 Oct; 21(27-30):4459-71. PubMed ID: 14505929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of the B subunit of cholera toxin in potentiating immune responses to the recombinant hemagglutinin/adhesin domain of the gingipain Kgp from Porphyromonas gingivalis.
    Zhang P; Yang QB; Balkovetz DF; Lewis JP; Clements JD; Michalek SM; Katz J
    Vaccine; 2005 Sep; 23(39):4734-44. PubMed ID: 15955601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
    De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
    Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
    de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
    Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of monophosphoryl lipid A augmentation of host responses to recombinant HagB from Porphyromonas gingivalis.
    Yang QB; Martin M; Michalek SM; Katz J
    Infect Immun; 2002 Jul; 70(7):3557-65. PubMed ID: 12065496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a cholera toxin B subunit Porphyromonas gingivalis fimbrial antigen fusion protein expressed in E. coli.
    Kim TG; Huy NX; Kim MY; Jeong DK; Jang YS; Yang MS; Langridge WH; Lee JY
    Mol Biotechnol; 2009 Feb; 41(2):157-64. PubMed ID: 18807220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeras of labile toxin one and cholera toxin retain mucosal adjuvanticity and direct Th cell subsets via their B subunit.
    Boyaka PN; Ohmura M; Fujihashi K; Koga T; Yamamoto M; Kweon MN; Takeda Y; Jackson RJ; Kiyono H; Yuki Y; McGhee JR
    J Immunol; 2003 Jan; 170(1):454-62. PubMed ID: 12496431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection.
    Weltzin R; Guy B; Thomas WD; Giannasca PJ; Monath TP
    Infect Immun; 2000 May; 68(5):2775-82. PubMed ID: 10768972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
    Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement-mediated killing of porphyromonas gingivalis 381 by the immunoglobulin G induced by recombinant 40-kDa outer membrane protein.
    Saito S; Hayakawa M; Hiratsuka K; Takiguchi H; Abiko Y
    Biochem Mol Med; 1996 Aug; 58(2):184-91. PubMed ID: 8812738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Egg yolk-derived immunoglobulin (IgY) against Porphyromonas gingivalis 40-kDa outer membrane protein inhibits coaggregation activity.
    Hamajima S; Maruyama M; Hijiya T; Hatta H; Abiko Y
    Arch Oral Biol; 2007 Jul; 52(7):697-704. PubMed ID: 17275778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.
    Haan L; Verweij WR; Holtrop M; Brands R; van Scharrenburg GJ; Palache AM; Agsteribbe E; Wilschut J
    Vaccine; 2001 Apr; 19(20-22):2898-907. PubMed ID: 11282201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CD80 and CD86 in host immune responses to the recombinant hemagglutinin domain of Porphyromonas gingivalis gingipain and in the adjuvanticity of cholera toxin B and monophosphoryl lipid A.
    Zhang P; Lewis JP; Michalek SM; Katz J
    Vaccine; 2007 Aug; 25(33):6201-10. PubMed ID: 17629367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant.
    Rask C; Fredriksson M; Lindblad M; Czerkinsky C; Holmgren J
    APMIS; 2000 Mar; 108(3):178-86. PubMed ID: 10752686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.